Manifest / 08
About Wolverine Source
A logbook kept on the BPC-157 TB-500 research record — what the pairing is, what it is not, and how every line here traces to its source.
What this site is
Wolverine Source keeps a logbook on the peer-reviewed research covering the BPC-157 TB-500 blend and each of its two constituents — a reading of the published record, not a service built on top of it. Nobody here holds a prescription pad: there are no clinicians on staff, no dosing passed to a reader, no diagnosis on offer. And nothing is for sale — no vials are made, stocked, sourced, or shipped from this address. What the desk produces is a plain accounting of what the science says, every quantitative line tied to its citation.
The site is built as a dispatch console — a two-lane manifest — because that structure fits the subject. Wolverine is not one molecule but two peptides traveling together, and the honest story of the pairing is partly a channel story: where the material comes from, what regulatory status it carries, and what the published evidence does and does not establish. Rendering each finding and each regulatory fact as a scannable manifest line is how we keep that record legible and verifiable.
What 'Source' means here
The word "Source" in the domain is editorial framing, not a claim about services. It marks a channel-of-record register — the vantage from which the published research and the regulatory status get tracked and logged — not a storefront and not a supply line. No treatment, no consult, no prescription, and no product changes hands here; nothing on this manifest is for sale.
That distinction matters because the subject invites confusion. The blend is marketed and discussed widely online; this site exists to summarize the underlying literature and the regulatory landscape, plainly and with citations, so a reader can see what is established, what is theoretical, and what is simply absent.
How it is sourced
Every quantitative claim on the site maps to a numbered entry in the full reference list: the preclinical studies for each constituent, recent systematic and narrative reviews, the doping-control literature, and FDA primary sources for the compounding status. Where the evidence is precise — a structural result, a reported animal-model dose — we state it precisely. Where it is absent — no controlled combination trial, no validated human pharmacokinetics — we state that too, in the same ink. The negative space on the manifest is part of the record.